Full Year 2024 DiaSorin SpA Earnings Call Transcript

Mar 14, 2025 / 04:30 PM GMT

Release Date Price: €95.44 (-2.67%)

Transcript

Key Points

Positve

Diasorin SpA (DSRLF) reported revenue and profitability in line with their plan, budget, and guidance for 2024, despite geopolitical tensions.
The company successfully launched the Liaison Complex with respiratory panels, leading to better-than-expected performance in the molecular segment.
Diasorin SpA (DSRLF) raised its guidance twice in 2024, indicating strong performance and confidence in their business strategy.
The US hospital strategy is working well, with the company achieving its target of serving 400 hospitals by year-end.
The company experienced double-digit growth in Europe, driven by successful placements and increasing volumes.

Negative

Diasorin SpA (DSRLF) continues to face difficulties in China, with double-digit revenue decreases due to local competition and economic conditions.
COVID-19 testing revenues have significantly decreased, impacting overall revenue growth.
The company faces tough competition in certain markets, such as Iran, affecting export revenues.
There is a mild start to the flu season, which has impacted the molecular diagnostics segment.
The company is experiencing inflationary pressures and increased manufacturing costs, particularly in their new Shanghai plant.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

DIAS.MI - DiaSorin SpA
Full Year 2024 DiaSorin SpA Earnings Call
Mar 14, 2025 / 04:30PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Good afternoon. This is the COSCO conference operator. Welcome and thank you for joining the DSR in full year 2024 results conference call. As a reminder, all participants are in listen-only mode.

After the presentation, there will be an opportunity to ask questions. Should anyone need assistance during the conference call, they may signal an operator by pressing and 0 on their telephone. At this time, I would like to turn the conference over to Mr. Carlo Rosa, CEO of Diasain. Please go ahead, sir.

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
Yes, thank you, operator. Good

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.